headaches

Natalizumab and Tyruko (natalizumab biosimilar) for treating highly active relapsing-remitting multiple sclerosis after at least one disease-modifying therapy: a systematic review and economic model

Natalizumab and Tyruko in Multiple Sclerosis Therapy Natalizumab is a monoclonal antibody that targets the alpha-4 integrin subunit, inhibiting the

Natalizumab and Tyruko (natalizumab biosimilar) for treating highly active relapsing-remitting multiple sclerosis after at least one disease-modifying therapy: a systematic review and economic model Read Post »

Variability in baseline concussion symptom burden and symptom reporting among UK student-athletes with neurodevelopmental, psychological or mental health conditions

Patient Demographics The study encompassed a diverse cohort of UK student-athletes, with an emphasis on those diagnosed with neurodevelopmental, psychological,

Variability in baseline concussion symptom burden and symptom reporting among UK student-athletes with neurodevelopmental, psychological or mental health conditions Read Post »

Scroll to Top